US BANCORP \DE\ - REATA PHARMACEUTICALS INC ownership

REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of REATA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$904,895
+3.2%
8,875
-8.0%
0.00%0.0%
Q1 2023$877,015
+3202.6%
9,646
+1280.0%
0.00%
Q4 2022$26,555
+89.7%
699
+27.8%
0.00%
Q3 2022$14,000
-65.9%
547
-59.1%
0.00%
Q2 2022$41,000
-31.7%
1,339
-26.6%
0.00%
Q1 2022$60,000
+1100.0%
1,824
+930.5%
0.00%
Q4 2021$5,000
-44.4%
177
+88.3%
0.00%
Q3 2021$9,000
-89.9%
94
-85.0%
0.00%
Q2 2021$89,000
+9.9%
627
-22.4%
0.00%
Q1 2021$81,000
-36.2%
808
-21.4%
0.00%
Q4 2020$127,000
+78.9%
1,028
+41.2%
0.00%
Q3 2020$71,000
-32.4%
728
+7.2%
0.00%
Q2 2020$105,000
+4.0%
679
-3.7%
0.00%
Q1 2020$101,000
+102.0%
705
+187.8%
0.00%
Q4 2019$50,000
+4900.0%
245
+1533.3%
0.00%
Q3 2019$1,000150.00%
Other shareholders
REATA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DekaBank Deutsche Girozentrale 17,000$2,9300.01%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 93,711$1,6120.00%
IFP Advisors, Inc 300$51,7080.00%
View complete list of REATA PHARMACEUTICALS INC shareholders